Max Healthcare Approves FY26 Financials, Recommends ₹2 Dividend, Expands Lucknow Hospital
Max Healthcare's Board approved FY26 audited financial results. A final dividend of ₹2 per share was recommended. The company approved the construction of Phase-I of its Lucknow hospital and the shifting of its registered office to Haryana. Mr. Anil Kumar Bhatnagar was re-appointed as a Director.
The dividend recommendation, hospital expansion, and registered office shift are material events that could impact investor sentiment and operational structure.
The company reported approved financial results, recommended a dividend, and approved significant expansion and corporate restructuring, indicating positive business momentum.
Max Healthcare Institute Limited announced the outcome of its Board of Directors meeting held on May 21, 2026. The Board approved the audited standalone and consolidated financial results for the fourth quarter and financial year ended March 31, 2026. M/s. S.R. Batliboi & Co. LLP, the statutory auditors, have issued their report with an unmodified opinion.
The company recommended a final dividend of ₹2 per equity share (20% of face value) for the financial year 2025-26, subject to shareholder approval. This dividend is to be paid/dispatched within 30 days from the conclusion of the forthcoming Annual General Meeting (AGM).
In other key decisions, the Board approved the re-appointment of M/s. Chandra Wadhwa & Co. as Cost Auditors for the financial year 2026-27. Additionally, the Board approved the re-classification of Radiant Life Care Hospital Foundation from ‘Promoter Group’ to ‘Public’ category, pending stock exchange approval.
The company also approved the construction of Phase-I of Max Super Specialty Hospital in Lucknow, which will accommodate approximately 712 beds. Furthermore, the Board approved the shifting of the company's registered office from Mumbai, Maharashtra, to Gurugram, Haryana, subject to member and regulatory approvals.
Mr. Anil Kumar Bhatnagar was re-appointed as a Non-Executive and Non-Independent Director for a further period of three years, effective October 1, 2026, subject to member approval at the AGM.
The Board meeting commenced at 12:07 pm IST and concluded at 3:44 pm IST. The financial results and auditor's reports are available on the company's website.
What to do with a filing like this
Max Healthcare Institute Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Max Healthcare Institute Limited. Read the original for the full detail.